Last reviewed · How we verify

NCT04683471

Pilot Trial of a System for Motor Function Recovery

Completed NA Last updated 13 April 2022
What this trial tests

NA trial testing Stimulator in Spinal Cord Diseases in 12 participants. Completed in 22 March 2022.

Timeline
30 November 2020
Primary endpoint
22 December 2021
22 March 2022

Quick facts

Lead sponsorNiche Biomedical, Inc. dba ANEUVO
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment12
Start date30 November 2020
Primary completion22 December 2021
Estimated completion22 March 2022
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Niche Biomedical, Inc. dba ANEUVO

Who can join

22 and older, any sex, with Spinal Cord Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Diseases

Currently open trials in the same condition.

Other Niche Biomedical, Inc. dba ANEUVO trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04683471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing